Page last updated: 2024-08-26

equol and Prostatic Neoplasms, Castration-Resistant

equol has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bosland, MC; Eskra, JN; Schlicht, MJ	1

Other Studies

1 other study(ies) available for equol and Prostatic Neoplasms, Castration-Resistant

Article	Year
Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer. The Prostate, 2019, Volume: 79, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Dietary Supplements; Docetaxel; Drug Synergism; Equol; Food-Drug Interactions; Genistein; Glycine max; Isoflavones; Male; Mice; Mice, Nude; Prostatic Neoplasms, Castration-Resistant; Random Allocation; Taxoids; Xenograft Model Antitumor Assays	2019

Article

Year

Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer.

The Prostate, 2019, Volume: 79, Issue:2

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Dietary Supplements; Docetaxel; Drug Synergism; Equol; Food-Drug Interactions; Genistein; Glycine max; Isoflavones; Male; Mice; Mice, Nude; Prostatic Neoplasms, Castration-Resistant; Random Allocation; Taxoids; Xenograft Model Antitumor Assays

2019